JP2014133739A - インダゾール誘導体またはピロロピリジン誘導体からなる医薬 - Google Patents

インダゾール誘導体またはピロロピリジン誘導体からなる医薬 Download PDF

Info

Publication number
JP2014133739A
JP2014133739A JP2013256668A JP2013256668A JP2014133739A JP 2014133739 A JP2014133739 A JP 2014133739A JP 2013256668 A JP2013256668 A JP 2013256668A JP 2013256668 A JP2013256668 A JP 2013256668A JP 2014133739 A JP2014133739 A JP 2014133739A
Authority
JP
Japan
Prior art keywords
group
optionally substituted
methyl
oxadiazol
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013256668A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014133739A5 (https=
Inventor
Kazuhiro Mizuno
和弘 水野
Junya Ikeda
淳哉 池田
Takanori Nakamura
高典 中村
Masakado Iwata
昌門 岩田
Hiromichi Otaka
広道 大▲高▼
Nana Goto
奈々 後藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Priority to JP2013256668A priority Critical patent/JP2014133739A/ja
Publication of JP2014133739A publication Critical patent/JP2014133739A/ja
Publication of JP2014133739A5 publication Critical patent/JP2014133739A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2013256668A 2012-12-12 2013-12-12 インダゾール誘導体またはピロロピリジン誘導体からなる医薬 Pending JP2014133739A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013256668A JP2014133739A (ja) 2012-12-12 2013-12-12 インダゾール誘導体またはピロロピリジン誘導体からなる医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012271099 2012-12-12
JP2012271099 2012-12-12
JP2013256668A JP2014133739A (ja) 2012-12-12 2013-12-12 インダゾール誘導体またはピロロピリジン誘導体からなる医薬

Publications (2)

Publication Number Publication Date
JP2014133739A true JP2014133739A (ja) 2014-07-24
JP2014133739A5 JP2014133739A5 (https=) 2015-01-15

Family

ID=51412300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013256668A Pending JP2014133739A (ja) 2012-12-12 2013-12-12 インダゾール誘導体またはピロロピリジン誘導体からなる医薬

Country Status (1)

Country Link
JP (1) JP2014133739A (https=)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9545405B2 (en) 2013-02-22 2017-01-17 Pfizer Inc. Pyrrolo[2,3-D]pyrimidine derivatives
US10328053B2 (en) 2016-08-26 2019-06-25 Gilead Sciences, Inc. Substituted pyrrolizine compounds and uses thereof
US10836769B2 (en) 2018-02-26 2020-11-17 Gilead Sciences, Inc. Substituted pyrrolizine compounds and uses thereof
US10966980B2 (en) 2014-08-12 2021-04-06 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine derivatives
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds
CN115417772A (zh) * 2022-09-26 2022-12-02 无锡双启科技有限公司 一种3-硝基-4-氟苯甲醚的制备方法
WO2025045837A1 (en) 2023-08-31 2025-03-06 Syngenta Crop Protection Ag Pesticidally active indazole compounds
US12577240B2 (en) 2020-07-11 2026-03-17 Pfizer Inc. Antiviral heteroaryl ketone derivatives

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050197335A1 (en) * 2004-02-18 2005-09-08 Daniel Marquess Indazole-carboxamide compounds as 5-HT4 receptor agonists
JP2006505544A (ja) * 2002-09-25 2006-02-16 ワイス エストロゲン受容体（ｅｒ）配位子としての置換４−（インダゾール−３−イル）フェノール及び炎症疾患治療におけるそれらの使用
US20060135764A1 (en) * 2004-12-22 2006-06-22 Theravance, Inc. Indazole-carboxamide compounds
JP2009543836A (ja) * 2006-07-14 2009-12-10 グラクソ グループ リミテッド インドール化合物
WO2012069917A1 (en) * 2010-11-26 2012-05-31 Lupin Limited Bicyclic gpr119 modulators

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006505544A (ja) * 2002-09-25 2006-02-16 ワイス エストロゲン受容体（ｅｒ）配位子としての置換４−（インダゾール−３−イル）フェノール及び炎症疾患治療におけるそれらの使用
US20050197335A1 (en) * 2004-02-18 2005-09-08 Daniel Marquess Indazole-carboxamide compounds as 5-HT4 receptor agonists
US20060135764A1 (en) * 2004-12-22 2006-06-22 Theravance, Inc. Indazole-carboxamide compounds
JP2009543836A (ja) * 2006-07-14 2009-12-10 グラクソ グループ リミテッド インドール化合物
WO2012069917A1 (en) * 2010-11-26 2012-05-31 Lupin Limited Bicyclic gpr119 modulators

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9549929B2 (en) 2013-02-22 2017-01-24 Pfizer Inc. Pyrrolo[2,3-D]pyrimidine derivatives
US9545405B2 (en) 2013-02-22 2017-01-17 Pfizer Inc. Pyrrolo[2,3-D]pyrimidine derivatives
US10966980B2 (en) 2014-08-12 2021-04-06 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine derivatives
US12161625B2 (en) 2016-08-26 2024-12-10 Gilead Sciences, Inc. Substituted pyrrolizine compounds and uses thereof
US10328053B2 (en) 2016-08-26 2019-06-25 Gilead Sciences, Inc. Substituted pyrrolizine compounds and uses thereof
US10874640B2 (en) 2016-08-26 2020-12-29 Gilead Sciences, Inc. Substituted pyrrolizine compounds and uses thereof
US10836769B2 (en) 2018-02-26 2020-11-17 Gilead Sciences, Inc. Substituted pyrrolizine compounds and uses thereof
US11420974B2 (en) 2018-02-26 2022-08-23 Gilead Sciences, Inc. Substituted pyrrolizine compounds and uses thereof
US12577240B2 (en) 2020-07-11 2026-03-17 Pfizer Inc. Antiviral heteroaryl ketone derivatives
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds
US11541034B2 (en) 2020-09-03 2023-01-03 Pfizer Inc. Nitrile-containing antiviral compounds
US11452711B2 (en) 2020-09-03 2022-09-27 Pfizer Inc. Nitrile-containing antiviral compounds
CN115417772A (zh) * 2022-09-26 2022-12-02 无锡双启科技有限公司 一种3-硝基-4-氟苯甲醚的制备方法
WO2025045837A1 (en) 2023-08-31 2025-03-06 Syngenta Crop Protection Ag Pesticidally active indazole compounds

Similar Documents

Publication Publication Date Title
JP2014510708A (ja) インダゾール誘導体およびピロロピリジン誘導体ならびにその医薬用途
JP2013010719A (ja) ベンズイミダゾロンおよびオキシインドール誘導体ならびにそれらの医薬用途
JP2014133739A (ja) インダゾール誘導体またはピロロピリジン誘導体からなる医薬
AU2013276617B2 (en) New diazaspirocycloalkane and azaspirocycloalkane
CA3222144A1 (en) Substituted indole compounds and methods of use thereof
DK2545045T3 (en) PIPERIDINE-4-YL-azetidine derivatives AS JAK1 INHIBITORS
JP6285444B2 (ja) 新規な二環式誘導体
TWI780511B (zh) Trpc 6抑制劑
WO2014092104A1 (ja) オキサジアゾール誘導体とその医薬用途
JP6715239B2 (ja) 置換２−アザ二環式化合物及びオレキシン受容体調節因子としてのその使用
JP5237807B2 (ja) ドーパミンｄ３受容体の調節因子としてのトリアゾール誘導体
JP2013515033A (ja) オレキシン受容体アンタゴニストとしてのジアザ−スピロ［５．５］ウンデカン類
CN114727991A (zh) 作为Kv1.3钾SHAKER通道阻断剂的芳基亚甲基杂环化合物
CN102639526B (zh) 作为5-ht4受体配体的1,2-二氢-2-氧代喹啉化合物
CA3234429A1 (en) Ras inhibitors, compositions and methods of use thereof
TW202309006A (zh) 作為ｓｉｇｍａ配體的新穎吡啶磺醯胺衍生物、其製備方法及用途，以及包含該吡啶－磺醯胺衍生物的醫藥組成物
TW202309017A (zh) 作為Ｓｉｇｍａ配體的１Ｈ－吡唑衍生物
WO1999028307A1 (en) Alicyclic acylated heterocyclic derivatives
TW202304448A (zh) 作為西格瑪配位基的新（高）哌啶基雜環
WO2026035543A1 (en) Salicylamides and methods of use thereof
HK40079910A (en) Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockers
AU2019257385A1 (en) Piperidin-4-yl azetidine derivatives as jak1 inhibitors

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140423

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140423

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20140423

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141125

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20141225

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150106

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150128

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150512